We are witnessing unprecedented times in the age of COVID-19 and its emerging worldwide impact.

In addition to the acute challenges health systems are now facing, the ‘secondary’ impact of the crisis on cancer and other non-communicable diseases, over the longer term has potential to result in an even greater loss of life. Currently, there are little robust data at the global level on the impact on health services access and cancer outcomes.  

The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, particularly those in low- and middle-income countries, as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis. 

The CCGMC is one of the three streams of work being conducted under the auspices of the COVID-19 and Cancer Taskforce,  which has been established by cancer leaders in many countries. The other two streams of work aim to:  

  • Coordinate efforts to synthesise and rapidly disseminate data to inform clinical judgements and support patient decision-making while facing lockdowns and potential irregular access to treatment and care providers; and 
  • Understand the impact on health workers and provide support 

while addressing cross-cutting issues such as: economic impact assessment, effects on cancer inequalities and cancer research as well as identifying new practices. 

To show your support please endorse the taskforce and consider how you can contribute. 

Graphic: Potential mechanism of impact on cancer outcomes.  Shows three interconnected gears labelled 'decreased survival', 'delayed diagnosis' and 'impact on cancer risk'